Correlates of postnatal human cytomegalovirus transmission in term babies in the first year

Piera d'Angelo1,2, Paola Zelini1, Federica Zavaglio1

  • 1Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Journal of Medical Virology
|September 20, 2023
PubMed

Insights

About one in five full-term infants contract human cytomegalovirus (HCMV) postnatally. Breast milk is the primary transmission route, with maternal saliva playing a minor role.

Area of Science:

  • Virology
  • Neonatal Immunology
  • Infectious Disease Transmission

Background:

  • Postnatal human cytomegalovirus (HCMV) infection is well-documented in preterm infants but less understood in term infants.
  • Understanding transmission dynamics in term infants is crucial for public health strategies.

Purpose of the Study:

  • To investigate the incidence and transmission routes of postnatal HCMV infection in full-term infants during their first year of life.
  • To correlate maternal factors like viral shedding and immune responses with infant infection.

Main Methods:

  • A cohort study involving 120 HCMV seropositive mothers and 122 newborns.
  • HCMV-DNA shedding was quantified in maternal and infant bodily fluids (saliva, breast milk, urine, vaginal secretions).
  • Maternal neutralizing antibody titers, T-cell responses, and breast milk immunoglobulin G were analyzed.

Main Results:

  • HCMV shedding was detected in 55.8% of mothers.
  • Postnatal HCMV infection occurred in 16.4% of infants within 3 months and 21.3% within the first year.
  • Viral shedding was most frequent in breast milk, with higher levels found in mothers of infected infants.

Conclusions:

  • Approximately 21.3% of full-term infants acquire HCMV infection postnatally within the first year.
  • Breast milk is identified as the predominant route for HCMV transmission to term infants.
  • Maternal saliva plays a minor role, while vaginal secretions appear negligible in postnatal transmission.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
342
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K